Xenon Pharmaceuticals Inc. cotiza a 36.44 USD y tiene una capitalización bursátil de $3.5B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders. Its product candidates include Azetukalner, a novel, potent Kv7 potassium channel opener which is in Phase 3 cl…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-1.11 | $-1.17 | $-1.31 |
| Estimado | $-1.15 | $-1.16 | $-1.20 | $-1.21 |
| Sorpresa | — | +4.3% | +2.5% | -8.3% |
| Métrica | XENE | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -4974.3% | -38.6% | -4935.7% |
| Net Margin | -4612.1% | -33.6% | -4578.6% |
| FCF Margin | -3732.2% | -13.9% | -3718.4% |
| ROE | -59.5% | -40.4% | -19.1% |
| ROA | -54.6% | -32.0% | -22.6% |
| Current Ratio | 13.42 | 2.84 | +10.58 |
| Debt / Equity | — | 0.28 | — |